WCG
ELV icon

Weaver Consulting Group’s Elevance Health ELV Stock Holding History

Weaver Consulting Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-58
Closed -$16K – 356
2020
Q3 		$16K Hold
58
– – 0.01% 446
2020
Q2 		$15K Hold
58
– – 0.01% 439
2020
Q1 		$13K Hold
58
– – 0.01% 397
2019
Q4 		$14K Hold
58
– – 0.01% 423
2019
Q3 		$17K Hold
58
– – 0.01% 376
2019
Q2 		$16K Hold
58
– – 0.01% 370
2019
Q1 		$16K Buy
+58
New +$16.8K ﹤0.01% 801

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Weaver Consulting Group's ELV Position: Q4 2020 in Review

Weaver Consulting Group sold out of Elevance Health (ELV) in Q4 2020, closing a stake of 58 shares — an estimated $16K sold.

Weaver Consulting Group first reported a position in ELV in Q1 2019 and held it in 7 quarters. The position peaked at $17K in Q3 2019. 1,170 funds tracked by Wall St. Rank hold ELV as of Q4 2020.

  • Weaver Consulting Group reported no remaining Elevance Health position as of Q4 2020 after selling out during the quarter.
  • Weaver Consulting Group sold 58 Elevance Health shares in Q4 2020, an estimated $16K.
  • Weaver Consulting Group first reported a position in Elevance Health in Q1 2019 and held it in 7 quarters.
  • Weaver Consulting Group's Elevance Health position peaked at $17K in Q3 2019.
  • 1,170 funds tracked by Wall St. Rank held Elevance Health as of Q4 2020.

Based on Weaver Consulting Group's 13F filing for Q4 2020, filed 29 Jan 2021.